In the laboratory analysis, the Hb level was significantly lower (p < 0.0001) in group 2–5 patients with GIST (12.5 g/dL) than in patients with leiomyoma/schwannoma (13.8 g/dL). This evidence concerns the gene GSTM1 and schwannoma.